ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,158,046 | -12.0% | 669,051 | -0.4% | 0.02% | -10.0% |
| Q2 2023 | $20,642,495 | +14.5% | 671,519 | +34.2% | 0.02% | +11.1% |
| Q1 2023 | $18,034,132 | +11.2% | 500,531 | +21.9% | 0.02% | +5.9% |
| Q4 2022 | $16,223,236 | -2.6% | 410,507 | -0.9% | 0.02% | -10.5% |
| Q3 2022 | $16,650,000 | -0.7% | 414,398 | +4.0% | 0.02% | +11.8% |
| Q2 2022 | $16,759,000 | +16.3% | 398,610 | +7.7% | 0.02% | +41.7% |
| Q1 2022 | $14,416,000 | +36.6% | 369,981 | +39.7% | 0.01% | +100.0% |
| Q4 2021 | $10,550,000 | +88.0% | 264,792 | +70.5% | 0.01% | +100.0% |
| Q3 2021 | $5,612,000 | -9.3% | 155,312 | +2.9% | 0.00% | 0.0% |
| Q2 2021 | $6,185,000 | +22.3% | 150,884 | +30.1% | 0.00% | 0.0% |
| Q1 2021 | $5,056,000 | +15.3% | 115,947 | +32.4% | 0.00% | +50.0% |
| Q4 2020 | $4,384,000 | – | 87,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |